| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.09.25 | Xebra Brands Ltd (2): Xebra's 1:10 rollback to be delayed until CTO revoked | 5 | Stockwatch | ||
| XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
| 19.09.25 | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 298 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 19, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025,... ► Artikel lesen | |
| 13.09.25 | Xebra Brands Ltd (2): Xebra Brands to roll back shares one for 10 Sept. 19 | 3 | Stockwatch | ||
| 13.09.25 | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 554 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025)... ► Artikel lesen | |
| 04.09.25 | CSE Bulletin: Suspension - XEBRA Brands Ltd. (XBRA) | 390 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 4 septembre/September 2025) - Effective immediately, XEBRA Brands Ltd. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt... ► Artikel lesen | |
| 04.09.25 | Xebra Brands Ltd (2): Xebra Brands suspended by CSE | 3 | Stockwatch | ||
| 04.09.25 | XFRA 9YC0: AUSSETZUNG/SUSPENSION | 311 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXEBRA BRANDS CL.A... ► Artikel lesen | |
| 22.08.25 | Xebra Brands Ltd: Xebra Brands Announces Issuance of Cease Trade Order | 510 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 22, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (XBRA:CSE)(XBRAF:OTC PINK)(9YC:FSE), a cannabis company, announces that the Company does not expect to... ► Artikel lesen | |
| 16.08.25 | Xebra Brands Ltd: Xebra Brands Announces Share Consolidation and Provides Update on MCTO | 653 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 15, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), a international cannabis company, announces that it intends to consolidate its issued and outstanding... ► Artikel lesen | |
| 02.08.25 | Xebra Brands Ltd: Xebra Provides Update on MCTO | 855 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 1, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTC PINK:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed... ► Artikel lesen | |
| 16.07.25 | Xebra Brands Ltd: Xebra Provides Update on Management Cease Trade Order | 333 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / July 16, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed... ► Artikel lesen | |
| 03.07.25 | Xebra Brands Ltd. Terminates Letter of Intent to Acquire BSK Holdings Inc.; Announces Delay in Completion of Annual Filings and MCTO; Announces Loan | 507 | ACCESS Newswire | Continued Partnership to Bring ELEMENTS CBD Product Line to U.S. Market VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0)... ► Artikel lesen | |
| 23.06.25 | Xebra Brands Ltd: Xebra Announces Corporate Update and Correction Notice of Press Release Announcing Grant of Management Cease Trade Order | 484 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. (CSE:XBRA) (the "Company" or "Xebra Brands") announces a correction to the Company's press release dated June 23, 2025 announcing... ► Artikel lesen | |
| 23.06.25 | Xebra Brands Ltd: Xebra Announces Delay in Filing Financial Statements | 358 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. ("Xebra") (XBRA:CSE)(XBRAF:OTCQB)(9YC:FSE), announces today that it was not in a position to file its audited annual financial statements... ► Artikel lesen | |
| 13.05.25 | Xebra Brands Ltd: Xebra Brands Advances Commercialization Efforts with NF Skin | 392 | ACCESS Newswire | Summer 2025 Launch of ELEMENTS CBD Product Line in United States VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading... ► Artikel lesen | |
| 24.04.25 | XFRA 9YC0: WIEDERAUFNAHME/RESUMPTION | 450 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 24.04.25 | Xebra Brands Ltd: Xebra Brands Announces Letter of Intent to Acquire CBD E-Commerce Company BSK Holdings Inc. | 565 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESS... ► Artikel lesen | |
| 23.04.25 | XFRA 9YC0: AUSSETZUNG/SUSPENSION | 740 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXEBRA BRANDS CL.A... ► Artikel lesen | |
| 15.04.25 | Xebra Brands Ltd: Xebra Brands Executes Manufacturing and Distribution Agreement to Launch CBD Product Line in the U.S. | 463 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 15, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading innovator in the North American cannabis sector, is pleased... ► Artikel lesen | |
| 10.04.25 | Xebra Brands Ltd: Xebra Brands Launches National RFP to Establish Cannabis Cultivation Partnerships Across Mexico | 416 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 10, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a trailblazer in the Mexican cannabis sector and the sole company legally... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 38,310 | -5,66 % | Bayer auf dem Prüfstand: Was die Lösung des Glyphosat-Streits für die Aktie bedeutet | Bayer hofft auf eine Lösung des Glyphosat-Rechtsstreits bis 2026. Was bedeutet das für die Aktie? Bayer hat in den verganngenen zwölf Monaten eine beeindruckende Aktienperformance von rund 90 Prozent... ► Artikel lesen | |
| AURORA CANNABIS | 3,075 | -3,60 % | Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom? | ||
| CANOPY GROWTH | 0,908 | -2,26 % | Is It Time to Dump Your Shares of Canopy Growth?? | ||
| TILRAY BRANDS | 6,370 | -2,15 % | MDMA-Herausforderer Bioxyne punktet mit 112% Umsatzplus. Und was macht Tilray? | ||
| INNOCAN PHARMA | 3,880 | -6,73 % | Innocan Pharma Corporation: FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time | HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"),... ► Artikel lesen | |
| CRONOS GROUP | 2,222 | -1,42 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| SYNBIOTIC | 2,270 | -2,78 % | EQS-News: SYNBIOTIC SE: Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Sonstiges
Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 60,50 | +3,42 % | Nektar Therapeutics Announces Research Collaboration with UCSF and Dr. Stephen Hauser for NKTR-0165, a Tumor Necrosis Factor Receptor 2 (TNFR2) Antibody, in Multiple Sclerosis | SAN FRANCISCO, Feb. 17, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced an academic research collaboration with the University of California... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 2,830 | -0,98 % | Dividendenbekanntmachungen (16.01.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBVIE INC US00287Y1091 1,73 USD 1,4902 EUR ABBVIE INC CDR CA00288K1084 0,2439 CAD 0,1512 EUR ALAMO GROUP INC US0113111076 0... ► Artikel lesen | |
| OPKO HEALTH | 1,020 | -3,77 % | OPKO Health, Inc.: OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results | MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces... ► Artikel lesen | |
| JAGUAR HEALTH | 0,793 | -1,49 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 27.02.2026 | Das Instrument UZ9 CA4577022078 INSPIRATION ENERGY CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 27.02.2026 und ex Kapitalmassnahme am 02.03.2026 The instrument UZ9 CA4577022078 INSPIRATION ENERGY... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 4,265 | -1,39 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) | Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as of December 26, 2025; SELLAS remains blinded to trial outcomesTiming of the... ► Artikel lesen | |
| XORTX THERAPEUTICS | 0,312 | -9,04 % | XORTX Therapeutics Inc. - 6-K, Report of foreign issuer | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| TALPHERA | 0,785 | +0,64 % | Talphera, Inc.: Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial | Enrolled 35 of the 70 patients in the ongoing NEPHRO-CRRT registrational study, supported by new target profile sites
Company to host a virtual investor and analyst... ► Artikel lesen |